Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis Oct 22, 2026 05:00AM
Thiogenesis Reports Results of 2026 Annual and Special Meeting of Shareholders and Provides Corporate Update Sep 21, 2026 04:00AM
Thiogenesis Engages Brisco Capital for Investor Relations Sep 3, 2026 06:00AM